3198 related articles for article (PubMed ID: 26124205)
21. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction.
Kutyifa V; Vermilye K; Solomon SD; McNitt S; Moss AJ; Daimee UA
Eur J Heart Fail; 2019 Mar; 21(3):360-369. PubMed ID: 30592353
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).
Kutyifa V; Naqvi SY; Brown M; McNitt S; Goldenberg I; Klein H; Moss AJ
Am J Cardiol; 2018 Jun; 121(12):1567-1574. PubMed ID: 29625702
[TBL] [Abstract][Full Text] [Related]
24. Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
Friedman DJ; Al-Khatib SM; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Olivas-Martinez A; Inoue LYT; Sanders GD
Circulation; 2023 Mar; 147(10):812-823. PubMed ID: 36700426
[TBL] [Abstract][Full Text] [Related]
25. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
26. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
[TBL] [Abstract][Full Text] [Related]
27. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
[TBL] [Abstract][Full Text] [Related]
28. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.
Imamura T; Kinugawa K; Nitta D; Komuro I
Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671
[TBL] [Abstract][Full Text] [Related]
29. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
31. Dyssynchrony and the risk of ventricular arrhythmias.
Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT.
Biton Y; Kutyifa V; Zareba W; Klein HU; Solomon SD; McNitt S; Polonsky B; Moss AJ; Goldenberg I
Heart Fail Rev; 2015 Sep; 20(5):535-43. PubMed ID: 26216033
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
[TBL] [Abstract][Full Text] [Related]
34. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
35. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
[TBL] [Abstract][Full Text] [Related]
36. Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
Mathias A; Moss AJ; McNitt S; Zareba W; Goldenberg I; Solomon SD; Kutyifa V
J Am Coll Cardiol; 2016 Sep; 68(12):1268-76. PubMed ID: 27634117
[TBL] [Abstract][Full Text] [Related]
37. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
[TBL] [Abstract][Full Text] [Related]
38. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.
Zusterzeel R; Curtis JP; Caños DA; Sanders WE; Selzman KA; Piña IL; Spatz ES; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Strauss DG
J Am Coll Cardiol; 2014 Sep; 64(9):887-94. PubMed ID: 25169173
[TBL] [Abstract][Full Text] [Related]
39. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
[TBL] [Abstract][Full Text] [Related]
40. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
